ID | 63969 |
フルテキストURL | |
著者 |
Makimoto, Go
Department of Allergy and Respiratory Medicine, Okayama University Hospital
Shimonishi, Atsushi
Department of Allergy and Respiratory Medicine, Okayama University Hospital
Ohashi, Kadoaki
Department of Allergy and Respiratory Medicine, Okayama University Hospital
ORCID
Kaken ID
researchmap
Ninomiya, Kiichiro
Department of Allergy and Respiratory Medicine, Okayama University Hospital
Kaken ID
Higo, Hisao
Department of Allergy and Respiratory Medicine, Okayama University Hospital
Kato, Yuka
Center for Innovative Clinical Medicine, Okayama University Hospital
Kaken ID
Fujii, Masanori
Department of Allergy and Respiratory Medicine, Okayama University Hospital
Ichihara, Eiki
Department of Allergy and Respiratory Medicine, Okayama University Hospital
Kaken ID
publons
Hotta, Katsuyuki
Center for Innovative Clinical Medicine, Okayama University Hospital
Kaken ID
publons
researchmap
Maeda, Yoshinobu
Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
Kaken ID
researchmap
Kiura, Katsuyuki
Department of Allergy and Respiratory Medicine, Okayama University Hospital
ORCID
Kaken ID
publons
researchmap
|
抄録 | Tepotinib, the novel MET-tyrosine kinase inhibitor, shows an antitumor effect for patients with non-small-cell lung cancer (NSCLC) harboring MET exon 14 skipping mutation. In January 2022, the AmoyDx (R) Pan Lung Cancer polymerase chain reaction Panel (AmoyDx (R) panel), which had a shorter turnaround time than the conventional test, was launched in Japan as a tepotinib companion test. We report a patient with an advanced MET-mutant NSCLC promptly diagnosed using the AmoyDx (R) panel and successfully treated with tepotinib. Although the patient's performance status (PS) worsened due to the rapid tumor progression and lung abscess formation, the tumor shrank immediately after tepotinib treatment with marked PS improvement.
|
キーワード | MET
Tepotinib
Non-small-cell lung cancer
|
発行日 | 2022
|
出版物タイトル |
Case Reports In Oncology
|
巻 | 15巻
|
号 | 2号
|
出版者 | Karger
|
開始ページ | 494
|
終了ページ | 498
|
ISSN | 1662-6575
|
資料タイプ |
学術雑誌論文
|
言語 |
英語
|
OAI-PMH Set |
岡山大学
|
著作権者 | © 2022 The Author(s).
|
論文のバージョン | publisher
|
PubMed ID | |
DOI | |
Web of Science KeyUT | |
関連URL | isVersionOf https://doi.org/10.1159/000524326
|
ライセンス | https://creativecommons.org/licenses/by-nc/4.0/
|